U.S. flag

An official website of the United States government

NM_004387.4(NKX2-5):c.355G>T (p.Ala119Ser) AND not specified

Germline classification:
Benign (1 submission)
Last evaluated:
Apr 2, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000171007.7

Allele description [Variation Report for NM_004387.4(NKX2-5):c.355G>T (p.Ala119Ser)]

NM_004387.4(NKX2-5):c.355G>T (p.Ala119Ser)

Gene:
NKX2-5:NK2 homeobox 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q35.1
Genomic location:
Preferred name:
NM_004387.4(NKX2-5):c.355G>T (p.Ala119Ser)
Other names:
p.A119S:GCG>TCG
HGVS:
  • NC_000005.10:g.173233189C>A
  • NG_013340.1:g.7124G>T
  • NM_001166175.2:c.*308G>T
  • NM_001166176.2:c.*154G>T
  • NM_004387.4:c.355G>TMANE SELECT
  • NP_004378.1:p.Ala119Ser
  • LRG_671t1:c.355G>T
  • LRG_671:g.7124G>T
  • LRG_671p1:p.Ala119Ser
  • NC_000005.9:g.172660192C>A
  • NM_001166175.1:c.*308G>T
  • NM_004387.3:c.355G>T
  • P52952:p.Ala119Ser
Protein change:
A119S; ALA119SER
Links:
UniProtKB: P52952#VAR_047869; OMIM: 600584.0015; dbSNP: rs137852684
NCBI 1000 Genomes Browser:
rs137852684
Molecular consequence:
  • NM_001166175.2:c.*308G>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001166176.2:c.*154G>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_004387.4:c.355G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000917901Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Benign
(Apr 2, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The ambiguous role of NKX2-5 mutations in thyroid dysgenesis.

van Engelen K, Mommersteeg MT, Baars MJ, Lam J, Ilgun A, van Trotsenburg AS, Smets AM, Christoffels VM, Mulder BJ, Postma AV.

PLoS One. 2012;7(12):e52685. doi: 10.1371/journal.pone.0052685. Epub 2012 Dec 28.

PubMed [citation]
PMID:
23285148
PMCID:
PMC3532205

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000917901.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: NKX2-5 c.355G>T (p.Ala119Ser) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00097 in 259522 control chromosomes in the gnomAD database, including 2 homozygotes. The observed variant frequency is approximately 194.2 fold of the estimated maximal expected allele frequency for a pathogenic variant in NKX2-5 causing Congenital Heart Disease phenotype (5e-06), strongly suggesting that the variant is benign. The variant, c.355G>T has been reported in the literature in individuals affected with Congenital Heart Disease, and the same publication reports experimental evidence evaluating an impact on protein function that showed variant behaves equal to wildtype NKX2-5 (vanEngelen_2012). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024